September #127 : Kick in the Butt - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Back to School

The Money Pit

Retro Virus

ONLINE EXCLUSIVE: Mixed Doubles




Old School

“C” Ya In Bed

Kick in the Butt

Dear Dairy

Magnum PIs: Protease inhibitor bulletin

Code Blueberry

The Porn Identity

Bye George!

Good, Dirty Fun

Deposit Slip




Blood Sport

United We Fall

U.S. Steal

A Capitol Punishment?

The Mourning Show

Crash

Hurts So Good




Editor’s Letter-Septmeber 2006

Mailbox-September 2006

Catch of the Month-September 2006



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV



email print

September 2006


Kick in the Butt

by Tim Horn

A new vaccine may ease therapy for anal lesions in both sexes

Human papilloma virus (HPV) causes anal lesions, which are common among positive men and women. Unlike less threatening anal warts, lesions can turn cancerous. And treating the pesky, hard-to-see (and -feel) growths can be a literal pain in the ass; current options include burning, cutting or freezing. But an experimental vaccine may soon put those painful therapy choices behind us.

Don’t confuse this therapeutic vaccine, dubbed HspE7, with Gardasil, the preventive HPV vax approved in June. Joel Palefsky, MD, a longtime HPV expert at the University of California at San Francisco, says Gardasil stimulates antibodies to prevent HPV from entering skin cells, while HspE7 has a therapeutic edge because it “works by stimulating an immune response to remove cells already infected with HPV.”

Palefsky conducted a recent study that showed that HspE7 (three injections into the thigh over eight weeks) was safe in 15 HIV positive men and women with high-grade anal lesions. Moreover, in four cases, the lesions became less severe; in another, they disappeared. He calls the data encouraging but adds that only larger studies will establish the vaccine’s usefulness. If tests go well, HspE7 could be ready for approval in a few years.

Men and women should make sure to get annual Pap smears to check for HPV anal lesions and treat any high-grade versions that show up. This is not something to sit on.


[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    soy_Ric
    Rochester
    New York


    Sexynyrican
    Brooklyn
    New York


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.